SCHEMBL7143635

SCHEMBL7143635

COc1ccc(COc2cc(NC(=O)OC(C)(C)C)c([N+](=O)[O-])cc2-c2ccccc2F)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
RAB9A P51151 4/20 0.45
MAPT P10636 2/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
NPC1 O15118 3/20 0.40
MAPK1 P28482 3/20 0.40
BCL2 P10415 3/20 0.39
CYP19A1 P11511 1/20 0.39
KDM4E B2RXH2 2/20 0.39
MCL1 Q07820 1/20 0.39
CASP3 P42574 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
CTSV O60911 1/20 0.39
CTSL P07711 1/20 0.39
MMP1 P03956 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7141097 0.86 RAB9A (0.46) MEN1KMT2ARAB9AMAPTSMN1; SMN2
SCHEMBL7140411 0.86 HDAC1 (0.46) MEN1KMT2ARAB9ANPC1KDM4E
SCHEMBL7146705 0.85 KDM4E (0.41) MEN1KMT2ARAB9AMAPTSMN1; SMN2
SCHEMBL6165508 0.84 MEN1 (0.38) MEN1KMT2ARAB9AMAPTALDH1A1
SCHEMBL7138027 0.84 SMN1; SMN2 (0.44) MEN1KMT2ARAB9AMAPTSMN1; SMN2
SCHEMBL7138538 0.83 RAB9A (0.41) MEN1KMT2ARAB9AMAPTSMN1; SMN2
SCHEMBL5557485 0.78 RAB9A (0.42) MEN1KMT2ARAB9AMAPTNPC1
SCHEMBL5562862 0.76 RAB9A (0.41) MEN1KMT2ARAB9AMAPTSMN1; SMN2
SCHEMBL7141631 0.76 ABCC1 (0.42) MEN1KMT2ARAB9AMAPTALDH1A1
SCHEMBL25381719 0.74 PKM (0.43) MEN1KMT2ARAB9AMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed